Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 10.
doi: 10.1007/s12020-025-04331-7. Online ahead of print.

Benefits of a 12 weeks-individually tailored physical activity program in patients with Cushing's disease in remission and controlled acromegaly

Luciana Martel-Duguech  1 , Helena Bascuñana  2 , Víctor Priego Corredor  3 , Oriol González-Viñuela  3 , Judith Vinyals Ribé  3 , Toni Caparrós Pons  3   4 , Susan M Webb  1   2   3   4   5   6 , Elena Valassi  7   8
Affiliations

Benefits of a 12 weeks-individually tailored physical activity program in patients with Cushing's disease in remission and controlled acromegaly

Luciana Martel-Duguech et al. Endocrine. .

Abstract

Background: Patients with controlled Cushing's disease (CD) and acromegaly (ACRO) often experience persistent musculoskeletal dysfunction and impaired quality of life (QoL) despite biochemical normalization. Although undergoing supervised physical activity is a clear unmet need of pituitary patients, evidence on the effectiveness of individually tailored exercise programs in these populations is scanty.

Objective: The aim of this pilot study was to evaluate the effectiveness of a 12-week individually tailored and supervised exercise program on muscle function and patient-reported outcomes (PROMs) in patients with biochemically controlled CD and ACRO.

Methods: Twenty patients (10 women with CD in remission, 10 men with controlled ACRO) participated in a structured program combining aerobic and resistance exercises, supervised by professional trainers, three times a week over 12 weeks. Outcomes assessed at baseline and post-intervention included, grip strength and physical performance on gait speed, timed up-and-go, chair stand test, muscle structure and quality on ultrasound examination and QoL, as evaluated using disease-specific (CushingQoL, AcroQoL) and generic (SF-12, PANAS, PHQ-9, and GAD-7) questionnaires.

Results: After the 12-week intervention, significant improvements were observed in physical performance tests (p < 0.05 for all parameters vs. baseline) in both CD and ACRO patients. Ultrasound-measured muscle thickness increased CD patients after completion of the program (p < 0.05), while a decreased echogenicity was found in ACRO patients (p < 0.05) CD patients demonstrated significant improvements in waist circumference, diastolic blood pressure (p < 0.05). No significant changes were observed in PROMs in either group after the intervention.

Conclusion: An individually tailored, supervised, 12-week exercise intervention significantly enhanced muscle structure and physical performance in patients with controlled CD and ACRO. Further randomized controlled studies are required to confirm the clinical effectiveness of incorporating supervised exercise programs into multidisciplinary management for pituitary disease patients.

Keywords: Acromegaly; Cushing’s disease; Exercise intervention; Muscle quality; Physical performance; Quality of life.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Conflict of interest: The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. M. Fleseriu, R. Auchus, I. Bancos, A. Ben-Shlomo, J. Bertherat, N.R. Biermasz et al., Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 9(12), 847–875 (2021). - PubMed - PMC
    1. A. Giustina, A. Barkan, A. Beckers, N. Biermasz, B.M.K. Biller, C. Boguszewski et al., A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J. Clin. Endocrinol. Metab. 105(4), e937–e946 (2020).
    1. F.F. Casanueva, A.L. Barkan, M. Buchfelder, A. Klibanski, E.R. Laws, J.S. Loeffler et al., Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20(5), 489–498 (2017). - PubMed - PMC
    1. E. Valassi, I. Chiodini, R.A. Feelders, C.D. Andela, M. Abou-Hanna, S. Idres et al., Unmet needs in Cushing’s syndrome: the patients’ perspective. Endocr. Connect. 11(7), e220027 (2022). - PubMed - PMC
    1. I. Kreitschmann-Andermahr, S. Siegel, C. Gammel, K. Campbell, L. Edwin, A. Grzywotz et al., Support needs of patients with Cushing’s disease and Cushing’s syndrome: results of a survey conducted in Germany and the USA. Int. J. Endocrinol. 2018, 9014768 (2018). - PubMed - PMC

LinkOut - more resources